dapsone has been researched along with Skin Ulcer in 25 studies
Skin Ulcer: An ULCER of the skin and underlying tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It occurs commonly during treatment of severe acne (eg, acne conglobata) with isotretinoin in young adolescent male patients." | 7.85 | Disfiguring ulcerative neutrophilic dermatosis secondary to doxycycline and isotretinoin in an adolescent boy with acne conglobata. ( Brassard, A; Fiorillo, L; Kuzel, P; Sotoodian, B, 2017) |
| "Phenotypic activity of these two routes of metabolism was assessed in 18 patients receiving longterm dapsone therapy for inflammatory dermatoses and was related to the development of dapsone toxicity." | 7.70 | Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors. ( Adedoyin, A; Bluhm, RE; Branch, RA; McCarver, DG, 1999) |
| "The basal level of blood ascorbic acid was studied in 70 cases of polar leprosy." | 7.67 | A study of blood ascorbic acid in leprosy. ( Bajaj, AK; Gupta, SC; Kumar, P; Singh, PA; Sinha, SN, 1984) |
| " It occurs commonly during treatment of severe acne (eg, acne conglobata) with isotretinoin in young adolescent male patients." | 3.85 | Disfiguring ulcerative neutrophilic dermatosis secondary to doxycycline and isotretinoin in an adolescent boy with acne conglobata. ( Brassard, A; Fiorillo, L; Kuzel, P; Sotoodian, B, 2017) |
| "Phenotypic activity of these two routes of metabolism was assessed in 18 patients receiving longterm dapsone therapy for inflammatory dermatoses and was related to the development of dapsone toxicity." | 3.70 | Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors. ( Adedoyin, A; Bluhm, RE; Branch, RA; McCarver, DG, 1999) |
| "The basal level of blood ascorbic acid was studied in 70 cases of polar leprosy." | 3.67 | A study of blood ascorbic acid in leprosy. ( Bajaj, AK; Gupta, SC; Kumar, P; Singh, PA; Sinha, SN, 1984) |
| "Ten patients with AATD panniculitis were included." | 1.48 | Alpha-1 antitrypsin deficiency panniculitis: clinical and pathologic characteristics of 10 cases. ( Gibson, LE; Johnson, EF; Tolkachjov, SN, 2018) |
| "Physical examination revealed several blisters and ulcers up to 2-cm in diameter around the anus." | 1.36 | Localized linear IgA/IgG bullous dermatosis. ( Natsuga, K; Shimizu, H; Shimizu, S; Shinkuma, S; Tsuchiya, K; Yasui, C, 2010) |
| "This progressive necrosis is analogous to that seen with brown recluse spider bites, where dapsone is an established mode of therapy, minimizing the area of tissue loss by a proposed antiinflammatory mechanism." | 1.31 | Dapsone for the treatment of doxorubicin extravasation injury in the rat. ( Bayati, S; Brown, RE; Neumeister, M; Sommer, NZ, 2002) |
| "All patients had oral and genital aphthae, and 22 of 25 patients had cutaneous lesions consistent with Behçet's disease." | 1.29 | Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement. ( Jorizzo, JL; Mangelsdorf, HC; White, WL, 1996) |
| "Tetanus in lepromatous leprosy is rare and reported occasionally as case reports only." | 1.27 | Tetanus in patient with lepromatous leprosy (I). ( Anilkumar, G; Nampalle, VB; Nathani, PJ; Sonvane, MV, 1988) |
| "The association between neutrophilic dermatoses, including pyoderma gangrenosum, subcorneal pustular dermatosis, and related entities, and IgA involvement, either IgA gammopathies and/or intraepidermal IgA deposits, is emphasized." | 1.27 | Atypical neutrophilic dermatosis with subcorneal IgA deposits. ( Cottenot, F; Janssen, F; Lemarchand-Venencie, F; Vignon-Pennamen, MD; Wallach, D, 1987) |
| "Malignant pyoderma is a rapidly progressive ulcerating process of unknown origin that predominantly affects the head and neck of young adults." | 1.27 | Malignant pyoderma or pyoderma gangrenosum of the head and neck? ( Briggaman, RA; Merritt, C; Wernikoff, S; Woodley, DT, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (48.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, A | 1 |
| Okiyama, N | 1 |
| Saito, K | 1 |
| Tanaka, R | 1 |
| Maruyama, H | 1 |
| Fujimoto, M | 2 |
| Sotoodian, B | 1 |
| Kuzel, P | 1 |
| Brassard, A | 1 |
| Fiorillo, L | 1 |
| Johnson, EF | 1 |
| Tolkachjov, SN | 1 |
| Gibson, LE | 1 |
| Asano, Y | 1 |
| Ishii, T | 1 |
| Ogawa, F | 1 |
| Kawakami, T | 1 |
| Kodera, M | 1 |
| Abe, M | 1 |
| Isei, T | 1 |
| Ito, T | 1 |
| Inoue, Y | 1 |
| Imafuku, S | 1 |
| Irisawa, R | 1 |
| Ohtsuka, M | 2 |
| Kadono, T | 1 |
| Kawaguchi, M | 1 |
| Kukino, R | 1 |
| Kono, T | 1 |
| Sakai, K | 1 |
| Takahara, M | 1 |
| Tanioka, M | 1 |
| Nakanishi, T | 1 |
| Nakamura, Y | 1 |
| Hashimoto, A | 1 |
| Hasegawa, M | 1 |
| Hayashi, M | 1 |
| Fujiwara, H | 1 |
| Maekawa, T | 1 |
| Matsuo, K | 1 |
| Madokoro, N | 1 |
| Yamasaki, O | 1 |
| Yoshino, Y | 1 |
| Le Pavoux, A | 1 |
| Tachibana, T | 1 |
| Ihn, H | 1 |
| Pardo, M | 1 |
| Bonifaz, A | 1 |
| Valencia, A | 1 |
| Araiza, J | 1 |
| Mejia, SA | 1 |
| Mena-Cedillos, C | 1 |
| Glardon, O | 1 |
| Pin, D | 1 |
| Shimizu, S | 1 |
| Natsuga, K | 1 |
| Shinkuma, S | 1 |
| Yasui, C | 1 |
| Tsuchiya, K | 1 |
| Shimizu, H | 1 |
| Bryant, SM | 1 |
| Pittman, LM | 1 |
| Sinha, SN | 1 |
| Gupta, SC | 1 |
| Bajaj, AK | 1 |
| Singh, PA | 1 |
| Kumar, P | 1 |
| Mangelsdorf, HC | 1 |
| White, WL | 1 |
| Jorizzo, JL | 1 |
| Bluhm, RE | 1 |
| Adedoyin, A | 1 |
| McCarver, DG | 1 |
| Branch, RA | 1 |
| Sommer, NZ | 1 |
| Bayati, S | 1 |
| Neumeister, M | 1 |
| Brown, RE | 1 |
| Espey, DK | 1 |
| Djomand, G | 1 |
| Diomande, I | 1 |
| Dosso, M | 1 |
| Saki, MZ | 1 |
| Kanga, JM | 1 |
| Spiegel, RA | 1 |
| Marston, BJ | 1 |
| Gorelkin, L | 1 |
| Meyers, WM | 1 |
| Portaels, F | 1 |
| Deming, MS | 1 |
| Horsburgh, CR | 1 |
| Anderson, JA | 1 |
| Lichter, MD | 1 |
| Welykyj, SE | 1 |
| Gradini, R | 1 |
| Solomon, LM | 1 |
| Anilkumar, G | 2 |
| Sonvani, MV | 1 |
| Chaudhary, VN | 1 |
| Nawaz, JM | 1 |
| Autee, GS | 1 |
| Sonvane, MV | 1 |
| Nampalle, VB | 1 |
| Nathani, PJ | 1 |
| Pittelkow, MR | 1 |
| Smith, KC | 1 |
| Su, WP | 1 |
| Nakamura, S | 1 |
| Nishihara, K | 1 |
| Nakayama, K | 1 |
| Hoshi, K | 1 |
| Wallach, D | 1 |
| Janssen, F | 1 |
| Vignon-Pennamen, MD | 1 |
| Lemarchand-Venencie, F | 1 |
| Cottenot, F | 1 |
| Wernikoff, S | 1 |
| Merritt, C | 1 |
| Briggaman, RA | 1 |
| Woodley, DT | 1 |
| Greenfield, L | 1 |
| Thompson, DM | 1 |
| Main, RA | 1 |
| Beck, JS | 1 |
| Albert-Recht, F | 1 |
| McDougall, AC | 1 |
| Rees, RJ | 1 |
| Oon, BB | 1 |
| Khong, KY | 1 |
| Greaves, MW | 1 |
| Plummer, VM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy: Comparison of 8 Weeks Standard Therapy (Rifampicin Plus Clarithromycin) vs. 4 Weeks Standard Plus Amoxicillin/Clavulanate Therapy [RC8 vs. RCA4][NCT05169554] | Phase 2 | 140 participants (Anticipated) | Interventional | 2021-12-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dapsone and Skin Ulcer
| Article | Year |
|---|---|
A pilot study of treatment of Buruli ulcer with rifampin and dapsone.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Dapsone; Drug Therapy, Combinatio | 2002 |
24 other studies available for dapsone and Skin Ulcer
| Article | Year |
|---|---|
Case of facial lupus erythematosus profundus with intractable ulceration successfully treated with dapsone.
Topics: Aged; Biopsy; Dapsone; Diagnosis, Differential; Face; Female; Folic Acid Antagonists; Humans; Pannic | 2017 |
Disfiguring ulcerative neutrophilic dermatosis secondary to doxycycline and isotretinoin in an adolescent boy with acne conglobata.
Topics: Acne Conglobata; Adolescent; Colchicine; Cyclosporine; Dapsone; Dermatologic Agents; Doxycycline; Hu | 2017 |
Alpha-1 antitrypsin deficiency panniculitis: clinical and pathologic characteristics of 10 cases.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Anti-Infective Agents; Dapso | 2018 |
The wound/burn guidelines - 4: Guidelines for the management of skin ulcers associated with connective tissue disease/vasculitis.
Topics: Antithrombins; Calcinosis; Calcium Channel Blockers; Connective Tissue Diseases; Dapsone; Endothelin | 2016 |
Actinomycetoma by Nocardia brasiliensis in a girl with Down syndrome.
Topics: Adolescent; Dapsone; Diagnostic Errors; Down Syndrome; Edible Grain; Female; Granuloma; Humans; Myce | 2008 |
[Diagnosis and therapy of a dog with an atypical eosinophilic cellulitis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Cellulitis; Dapsone; Dermatitis; Dogs | 2010 |
Localized linear IgA/IgG bullous dermatosis.
Topics: Administration, Oral; Aged; Anal Canal; Autoantibodies; Autoantigens; Biopsy; Blister; Collagen Type | 2010 |
Dapsone use in Loxosceles reclusa envenomation: is there an indication?
Topics: Adult; Anti-Infective Agents; Dapsone; Humans; Male; Methemoglobinemia; Phosphoric Diester Hydrolase | 2003 |
A study of blood ascorbic acid in leprosy.
Topics: Ascorbic Acid; Dapsone; Erythema Nodosum; Humans; Leprosy; Skin Ulcer; Socioeconomic Factors | 1984 |
Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Colchic | 1996 |
Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
Topics: Acetylation; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Female; Gangrene; Humans; Hydr | 1999 |
Dapsone for the treatment of doxorubicin extravasation injury in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Doxorubicin; Extravasation of Diagnostic | 2002 |
Malignant pyoderma.
Topics: Dapsone; Female; Humans; Middle Aged; Pyoderma; Skin; Skin Ulcer; Triamcinolone | 1978 |
Superficial granulomatous pyoderma.
Topics: Adult; Chronic Disease; Dapsone; Diagnosis, Differential; Granuloma; Humans; Male; Minocycline; Pyod | 1991 |
Tetanus in leprosy patient (II).
Topics: Dapsone; Humans; Knee Injuries; Leprosy; Male; Middle Aged; Seizures; Skin Ulcer; Tetanus | 1988 |
Tetanus in patient with lepromatous leprosy (I).
Topics: Adult; Dapsone; Foot Diseases; Humans; Leprosy, Lepromatous; Male; Seizures; Skin Ulcer; Tetanus | 1988 |
Alpha-1-antitrypsin deficiency and panniculitis. Perspectives on disease relationship and replacement therapy.
Topics: Adult; Aged; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Blood Proteins; Dapsone; Debrideme | 1988 |
Febrile ulceronecrotic Mucha-Habermann's disease and its successful therapy with DDS.
Topics: Adult; Dapsone; Dermatomycoses; Humans; Male; Pityriasis; Skin Ulcer | 1986 |
Atypical neutrophilic dermatosis with subcorneal IgA deposits.
Topics: Adult; Dapsone; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Neutrophils; Skin; | 1987 |
Malignant pyoderma or pyoderma gangrenosum of the head and neck?
Topics: Adult; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Female; Human | 1987 |
Leprosy in Ceylon.
Topics: Adolescent; Adult; Child; Child, Preschool; Dapsone; Female; Humans; Leprosy; Male; Skin Ulcer; Soci | 1970 |
Studies on a patient with leucocytoclastic vasculities 'pyoderma gangrenosum' and paraproteinaemia.
Topics: Antigens, Bacterial; Biopsy; Blood Protein Disorders; Blood Protein Electrophoresis; Dapsone; Erythe | 1973 |
Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae.
Topics: Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifam | 1973 |
Trophic skin ulceration of leprosy: skin and serum zinc concentrations.
Topics: Biopsy; Dapsone; Dermatitis Herpetiformis; Humans; Keratins; Leprosy; Mycobacterium leprae; Protein | 1974 |